Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases.

Autor: Puigdelloses M; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain., González-Huárriz M; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., García-Moure M; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Martínez-Vélez N; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Esparragosa Vázquez I; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain., Bruna J; Department of Neurology, Hospital de Bellvitge, Barcelona, Spain., Zandio B; Department of Neurology, Complejo Hospitalario de Navarra, Pamplona, Spain., Agirre A; POLYMAT, University of the Basque Country, San Sebastian, Spain., Marigil M; Division of Neurosurgery, Lariboisière University Hospital, Paris, France., Petrirena G; Service de Neuro-Oncologie, Hôpital de la Timone, Marseille, France., Nuñez-Córdoba JM; Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Preventive Medicine and Public Health, Medical School, Universidad de Navarra, Pamplona, Spain., Tejada-Solís S; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Department of Neurosurgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain., Díez-Valle R; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Department of Neurosurgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain., Gállego-Culleré J; Department of Neurology, Complejo Hospitalario de Navarra, Pamplona, Spain., Martínez-Vila E; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain., Patiño-García A; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Alonso MM; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Gállego Pérez-Larraya J; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.; Program in Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2020 Jan 31; Vol. 2 (1), pp. vdaa010. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).